News / Health

New Therapy for Peanut Allergy Shows Promise

Similar to allergy shots for dust and pollen, feeding peanuts in tiny amounts is designed to reprogram the young patients’ immune system so peanuts don’t provoke life-threatening reactions.
Similar to allergy shots for dust and pollen, feeding peanuts in tiny amounts is designed to reprogram the young patients’ immune system so peanuts don’t provoke life-threatening reactions.
Jessica Berman
To someone with a peanut allergy, accidentally ingesting a product containing even tiny amounts of the legume can trigger a potentially life-threatening reaction.  But researchers have found that when patients were given miniscule daily doses of peanut powder, they were able to build tolerance to the deadly food allergen.  
 
There is currently no allergy shot to desensitize individuals with a peanut allergy. The best treatment is to avoid all foods that might contain peanuts, which - in some people - can cause a potentially fatal reaction called anaphylaxis, in which the airways tighten and restrict breathing.  The only treatment is a rescue shot of epinephrine, which opens the airways. Those with the allergy often carry an emergency shot with them.
 
It might seem dangerous to give these people an oral dose of peanut powder.  But that’s exactly what U.S. researchers did in a new multi-center clinical trial. 
 
Wesley Burks, chairman of the department of pediatrics at the University of North Carolina School of Medicine in Chapel Hill, led the study.  He says 20 peanut-sensitive adolescents at two centers were given liquid containing miniscule amounts of peanut powder which they held under their tongue for two minutes before swallowing, while 20 received a placebo, or inactive, liquid. 
 
Every day, according to Burks, scientists increased the amount of peanut in the liquid by a tiny fraction.
 
“Before the study, they only could eat a third of a peanut.  At the end of the study they could tolerate three peanuts.  So that difference changed.  What we don’t know is how long do you need to continue the therapy and then you need to stop it so that change is permanent," he said. 
 
More studies will be conducted to find that out.  The SLIT trial, which stands for Sub-Lingual or beneath-the-tongue Immuno-Therapy, shows promise in desensitizing people with severe peanut allergies; after 44 weeks, adolescents in the study could tolerate ten times as much peanut as before the trial, compared to subjects who received an inactive liquid, according to Burks. 
 
The researcher cautions those with peanut allergies not to try desensitizing themselves.  Microdoses measured in just billionths of a gram of peanut power were used in the trial, doses that could not be replicated at home.
 
"We were unbelievably safe in trying to administer the product.  And it is not something that's ready for practice or ready for home use, because for peanut-allergic patients, there's too many dangers in doing that," he said. 
 
The study on treating peanut allergy with sublingual therapy is published in the Journal of Allergy and Clinical Immunology.

You May Like

Karzai's Legacy: Missed Opportunities?

Afghanistan's president leaves behind a much different nation than the one he inherited, yet his legacy from 13 years in power is getting mixed reviews More

Secret Service Chief Under Fire for White House Security Breach

Julia Pierson faces tough questions from lawmakers after recent intrusion at White House, says: 'It is clear that our security plan was not executed properly' More

Frustrated, Liberian Students Want Ebola Fight Role

Thousands have volunteered to go to counties, rural villages to talk to people in their language about deadly virus More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Malaysia Struggles to Stop People Joining Jihadi
X
Mahi Ramakrishnan
September 30, 2014 2:16 PM
Malaysian authorities say militant groups like the so-called "Islamic State" have used social media to entice at least three dozen Malaysian Muslims to fight in what they call "jihad" in Syria and Iraq. As Mahi Ramkrishnan reports from Kuala Lumpur, counterterrorism police are deeply worried about what could happen when these militants return home.
Video

Video Malaysia Struggles to Stop People Joining Jihad

Malaysian authorities say militant groups like the so-called "Islamic State" have used social media to entice at least three dozen Malaysian Muslims to fight in what they call "jihad" in Syria and Iraq. As Mahi Ramkrishnan reports from Kuala Lumpur, counterterrorism police are deeply worried about what could happen when these militants return home.
Video

Video Could US Have Done More to Stop Rise of Islamic State?

President Obama says airstrikes against Islamic State militants in Syria will likely continue for some time because, in his words, "there is a cancer that has grown for too long." So what if President Obama had acted sooner in Syria to arm more-moderate opponents of both the Islamic State and the Syrian government? VOA State Department Correspondent Scott Stearns reports from the United Nations.
Video

Video Treasure Hunters Seek 'Hidden Treasure' in Central Kenya

Could a cave in a small village in central Kenya be the site of buried treasure? A rumor of riches, left behind by colonialists, has some residents dreaming of wealth, while others see it as a dangerous hoax. VOA's Gabe Joselow has the story.
Video

Video Iran's Rouhani Skeptical on Syria Strikes

Iranian President Hassan Rouhani expressed skepticism Friday that U.S.-led airstrikes in Iraq and Syria could crush Islamic State militants. From New York, VOA’s Margaret Besheer reports the president was also hopeful that questions about Iran’s nuclear program could be resolved soon.
Video

Video US House Speaker: Congress Should Debate Authorization Against IS

As wave after wave of U.S. airstrikes target Islamic State militants, the speaker of the Republican-controlled House of Representatives says he would be willing to call Congress back into session to debate a formal, broad authorization for the use of military force. VOA’s Michael Bowman reports from Washington, where legislators left town 10 days ago for a seven-week recess.
Video

Video Ebola Patients Find No Treatment at Sierra Leone Holding Center

At a holding facility in Makeni, central Sierra Leone, dozens of sick people sit on the floor in an empty university building. They wait in filthy conditions. It's a 16-hour drive by ambulance to Kailahun Ebola treatment center. Adam Bailes was there and reports on what he says are some of the worst situations he has seen since the beginning of this Ebola outbreak. And he says it appears case numbers may already be far worse than authorities acknowledge.
Video

Video Identifying Bodies Found in Texas Border Region

Thousands of immigrants have died after crossing the border from Mexico into remote areas of the southwestern United States in recent years. Local officials in south Texas alone have found hundreds of unidentified bodies and buried them in mass graves in local cemeteries. Now an anthropologist and her students at Baylor University have been exhuming bodies and looking for clues to identify them. VOA’s Greg Flakus has more from Waco, Texas.
Video

Video Ebola Robs Liberians of Chance to Say Good-Bye to Loved Ones

In Liberia, where Ebola has killed more than 1,500 people, authorities have worked hard to convince people to allow specialized burial teams to take away dead bodies. But these safety measures, while necessary, make it hard for people to say good bye to their loved ones. VOA's Anne Look reports on the tragedy from Liberia.
Colonel Steve ‘Spiros’ Pisanos left Greece and came to the U.S. to learn to fly. He flew fighters for the Allies in World War II, narrowly escaping death multiple times.Colonel Steve ‘Spiros’ Pisanos left Greece and came to the U.S. to learn to fly. He flew fighters for the Allies in World War II, narrowly escaping death multiple times.

AppleAndroid